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Abstract Substance use disorder is a chronic condition of
compulsive drug seeking and use that is mediated by
stable changes in central reward pathways. Repeated use
of abused drugs causes persistent alterations in gene
expression responsible for the long-term behavioral and
structural changes. Recently, it has been suggested that
epigenetic mechanisms are responsible in part for these
drug-induced changes in gene expression. One of the
alluring aspects of epigenetic regulation of gene expres-
sion is that epigenetic mechanisms may provide transient
and potentially stable conditions that in turn may ulti-
mately participate in the molecular mechanisms required
for neuronal changes subserving long-lasting changes in
behavior. This review describes epigenetic mechanisms of
gene regulation and then discusses the emerging role of
epigenetics in drug-induced plasticity and behavior. Un-
derstanding these mechanisms that establish and maintain
drug-dependent plasticity changes may lead to deeper
understanding of substance use disorders as well as novel
approaches to treatment.
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Introduction
Drug addiction is a disorder of compulsive drug seeking and
use despite the associated negative consequences. It is a
chronic condition such that even after long periods of
abstinence, addicted individuals remain prone to relapse.
Drugs of abuse are known to change neuronal structure and
function in specific brain regions, resulting in persistent
changes at the molecular, cellular, systems, and behavioral
levels.Forexample,cocaineproduceslong-termbrainchanges
that underlie addiction in part by activating certain genes.
These changes are very long lasting; understanding how they
are established and maintained is a key open question.
Preclinical research has identified neuroadaptive changes
induced by drugs of abuse. These alterations in structural
and behavioral plasticity are still evident up to 1 year after
drug treatment in rodents [1]. Changes in gene expression
are thought to underlie these structural and behavioral
changes. Transcription factors such as ΔFosB and cyclic
adenosine monophosphate response element–binding
(CREB) protein regulate gene expression implicated in
drug-induced plasticity [2]. A transcription factor is defined
as a regulatory protein that binds to specific sequences in
DNA and affects transcription of specific genes. However,
transcription is not occurring on naked DNA, but rather in
the context of chromatin, providing an additional level of
complexity that is not yet fully understood. Chromatin is
the protein complex that condenses and organizes genomic
DNA (described in more detail subsequently). Thus, gene
expression requires the orchestrated effort of not only
transcription factors, but also very specific enzymatic
protein complexes that modify chromatin structure to
regulate gene expression.
Recently it has been shown that transcription factors
implicated in regulating gene expression associated with
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enzymes that lead to long-lasting changes in gene expres-
sion [3]. Why is it critical to understand these chromatin-
modifying mechanisms involved in the regulation of gene
expression? The answer is that these mechanisms establish
and maintain gene expression profiles that dictate cellular
function in a persistent manner [4].
As chromatin-modifying mechanisms can change gene
expression without changing the DNA sequence of regula-
tory elements driving gene expression, chromatin modifi-
cation is an epigenetic mechanism of gene regulation (the
prefix epi- meaning on, upon, or above). The preclinical
research showing that these epigenetic mechanisms may be
involved in drug-dependent changes in plasticity and
behavior is critical for our understanding of drug addiction.
These findings have profound implications for our under-
standing of the mechanisms that establish and maintain
drug-dependent plasticity changes, and for potential novel
avenues for treatment of drug addiction.
The purpose of this review is to examine the contribution
of current literature to our understanding of the role of
epigenetic mechanisms involved in substance use disorders.
We begin by providing critical background in the field of
epigenetics. Next, we describe the transcription factors
important for mediating gene expression underlying drug-
induced plasticity and behavior. Then we discuss the
recruitment of chromatin-modifying enzymes by these
transcription factors and the resulting effect on behavior.
We conclude with a short summary on the implications of
these findings and their impact on understanding and
treating drug addiction.
Defining Epigenetics
Epigenetics is the study of changes in the regulation of gene
expression and gene-product activity that are not dependent
on DNA sequence. The term epigenetics was originally
coined by C. H. Waddington in 1942 to describe the
examination of “causal mechanisms” whereby “the genes of
the genotype bring about phenotypic effects” [5]. The term
has now taken on several new definitions, especially in the
neurosciences. In non-neuroscience fields, the term refers to
a stably heritable phenotype resulting from changes in a
chromosome without alterations in the DNA sequence [6].
In a recent book on epigenetics by Allis et al. [7•], one can
find two different definitions. In one section, epigenetics is
defined as “change in phenotype that is heritable but does
not involve DNA mutation.” In another section, epigenetics
is defined as “changes in gene transcription through
modulation of chromatin, which is not brought about by
changes in the DNA sequence.” Notably, the term heritable
is not part and parcel of the latter definition. As neuro-
scientists are by definition interested in the function of
neurons, which are postmitotic differentiated cells, the
definition of epigenetics normally used by neuroscientists
has also dropped the heritable component [8–10••, 11].
As the number of publications relating to epigenetics
rose from 50 in 1989 to nearly 6000 in 2008, it is obvious
that regardless of how researchers define epigenetics, it has
taken a central position in research. The National Institutes
of Health describes epigenetics as “refer[ring] to both
heritable changes in gene activity and expression (in the
progeny of cells or of individuals) and also stable, long-
term alterations in the transcriptional potential of a cell that
are not necessarily heritable” [12]. This is the definition of
epigenetics to which we adhere in this review.
Chromatin Modification, Chromatin Remodeling, Histone
Variants, and DNA Methylation
The basic repeating unit of chromatin is the nucleosome,
which is made up of a histone octamer that interacts with
approximately 147 bp of genomic DNA per nucleosome.
The histone octamer contains pairs of histone H2A, H2B,
H3, and H4. The aminoterminal tails of these core histone
proteins are the sites of several post-translational modifica-
tions (eg, acetylation, methylation, phosphorylation) carried
out by an equally large number of histone-modifying
enzymes (eg, acetyltransferases, deacetylases, methyltrans-
ferases, demethylases, kinases) [13•]. The manipulation of
chromatin via the addition of functional groups to histone
tails is referred to as chromatin modification, which serves
two main purposes. The first is to provide recruitment
signals for nonhistone proteins (eg, transcription factors)
involved in transcriptional activation and silencing [13•,
14]. The second is to relax chromatin by disrupting contacts
between nucleosomes and interactions between histone tails
and genomic DNA (Fig. 1)[ 13•]. The functional conse-
quence of these modifications is discussed in the next
section. Importantly, chromatin modification should not be
confused with chromatin remodeling, which refers to
adenosine triphosphate-dependent enzymatic complexes
(eg, SWI/SNF, ISWI, INO80, NURD) that restructure,
mobilize, and remove nucleosomes to regulate access to
genomic DNA for transcriptional activation [15, 16].
Chromatin structure also may be manipulated and regulated
via histone variant incorporation (eg, H3.3, macroH2A,
H2AZ, H2AX) [17]. Thus, epigenetic regulation of tran-
scription may be thought of as the coordinated interplay of
mechanisms (eg, chromatin-modifying enzymes, nucleo-
some remodeling complexes, histone variant incorporation,
DNA methylation) that translates incoming signaling events
by altering chromatin structure in a specific and precise
manner that in turn regulates gene expression profiles for
defined cellular functions. An important question then is
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dependent changes in plasticity and behavior.
Emerging Role of Epigenetics in Drug-induced
Plasticity and Behavior
To investigate the mechanisms involved in the establishment
and maintenance of drug dependence, it is necessary to work
with an animal model. Rodents are the most tractable system
in that genetic and pharmacologic manipulations allow for the
elucidation of pathways underlying drug-induced behavior.
Several rodent behavioral paradigms are used to measure
different aspects of drug-seeking and drug-taking behaviors.
These models are described in Table 1.M o s tw o r ko n
epigenetic mechanisms with respect to drug abuse has been
done in cocaine research; thus, findings are described
primarily for this drug.
Transcription Factors Known to Mediate Gene Expression
Underlying Drug-induced Plasticity and Behavior
Acommonmechanismofmanyabuseddrugs isthe activation
of certain transcription factors that induce patterns of gene
expression in central reward pathways, which is distinct from
that of nonaddictive drugs [18]. Through the regulation of
genes, transcription factors can lead to adaptive changes in
neuronal structure and function [19]. The best-characterized
transcription factors in drug addiction are CREB and ΔFosB
[20]. Temporally, CREB is induced rapidly following each
drug treatment and then returns to baseline after a few hours.
In contrast, ΔFosB accumulates slowly after each drug
exposure and is highly stable for months after cessation. In
addition to temporal differences in activation, these tran-
scription factors also have been shown to mediate distinct
aspects of drug addiction.
In animal models, experimental approaches that artifi-
cially increase or decrease CREB function demonstrate that
its activation leads to a negative state of decreased reward
and increased drug tolerance and dependence (Table 2)
[20]. CREB is induced in reward-related brain regions, such
as the nucleus accumbens (NAc), not only by drug
administration but also in response to drug-paired cues
using the cocaine conditioned place preference (CPP)
model (Table 1)[ 21]. To further characterize the contribu-
tion of CREB to reward-related behaviors, several
approaches have been used. Using herpes simplex virus to
deliver wild-type (normal form) CREB or a mutant form of
CREB (mCREB), transient overexpression can be induced
when the virus is infused into a specific brain region (eg,
the NAc). mCREB can bind to DNA but cannot recruit
transcriptional machinery because a mutation in the kinase
inducible domain prevents phosphorylation of CREB, which
normallyresultsintheactivationofCREB.Thus,themutation
Fig. 1 Histone acetyltransferases (HATs) and histone deacetylases
(HDACs) have opposing activities. Nucleosomes, shown as blue
barrels, are composed of histone octamers that are involved in binding
DNA. Histone N-terminal tails, shown in purple (left nucleosome)o r
in green (right nucleosome), contain residues that directly interact with
the genomic DNA. In a transcriptionally silent state (left nucleosome),
positively charged lysine residues interact with the negatively charged
DNA phosphate backbone, whereas in a transcriptionally active state
(right nucleosome), lysine residues are modified by acetyl groups that
neutralize a lysine’s positive charge. Transcriptional coactivators such
as cyclic adenosine monophosphate response element–binding protein
(CBP) are histone acetyltransferases that acetylate lysine residues on
histone N-terminal tails. This acetylated state correlates with tran-
scriptional activation. The opposing activity is carried out by HDACs,
which remove acetyl groups from lysine residues, correlating with
transcriptional silencing. Competitive inhibitors of HDACs (eg,
trichostatin A [TSA], suberoylanilide hydroxamic acid [SAHA],
sodium butyrate [NaBut], and valproic acid [VPA]) directly interact
with and prevent HDACs from deacetylating lysines, thus inducing a
hyperacetylated and transcriptionally active state
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[22]. Behavioral studies using viral overexpression of the
wild-type CREB have found that increased CREB expres-
sion in the NAc results in a decrease in cocaine’sr e w a r d i n g
value as measured by CPP [22, 23]. Conversely, expression
of mCREB leads to enhanced cocaine reward at very low
drug doses [22, 23]. These findings suggest that CREB
activity in the NAc decreases cocaine reward, although the
role of CREB in reward may be region specific. Opposing
reward behaviors are observed when CREB is infused into
two distinct subregions of the ventral tegmental area, a
dopaminergic nucleus, suggesting that it may have different
roles within the reward circuitry [24].
Genetic manipulations also result in impaired CREB
activity. CREBαΔ mutant mice lack the α and Δ isoforms
of CREB, drastically reducing its activity [25]. Transgenic
mice expressing KCREB, a mutant form of CREB that
heterodimerizes with the wild-type form, prevent DNA
binding primarily in the dorsal striatum and reduce CREB-
mediated transcription [26]. These genetic models with
decreased CREB activity show enhanced CPP and sensitiza-
tion to cocaine compared with wild-type controls [25, 26],
further supporting CREB mediation of the negative aspects
of cocaine. However, a reduction in NAc CREB by antisense
infusions reduces cocaine self-administration behavior [27].
Although this may seem paradoxical, the dissociation may be
a result of the behavior tasks measuring different stages of
addiction.TheCPPandsensitizationstudiestestedforchanges
during the acquisition phase, whereas the self-administration
study was conducted in animals that had already acquired and
maintained drug response. Overall, these findings suggest that
CREB influences early drug-seeking behavior.
ΔFosB, which accumulates slowly after each drug
exposure, seems to mediate the positive rewarding and
sensitizing effects of abused drugs. Inducible ΔFosB over-
expression results in increased cocaine-induced locomotion
and CPP [28]. Furthermore, it increases the motivation to
self-administer cocaine [29]. ΔFosB is one of the most
persistently upregulated proteins after drug exposure, but it is
still degraded and returns to predrug levels after 1 month to
2m o n t h s[ 20]. This suggests that the ΔFosB protein itself
does not maintain drug dependence; instead, persistent
alterations in ΔFosB-regulated genes may be responsible.
Transcription Factors Implicated in Drug-induced Plasticity
and Behavior Recruit Chromatin-modifying Enzymes
Drug-associated plasticity is a product of gene activation
triggered in part by the previously described transcription
factors. However, gene expression also requires the coordi-
nated effort of enzymatic protein complexes that modify
chromatin structure. Cocaine exposure causes an overall
increase in gene expression in the NAc, and many of these
genes are regulated byCREB and ΔFosB [30]. Because there
are many possible histone modifications and a staggering
combinatorial complexity to the possible patterns of histone
modifications present at any given promoter (the specific
upstream sequence in DNA that coordinates expression of a
gene), new and powerful techniques have been developed to
begin to understand this complexity and what it may predict
with respect to the expression of a given gene. One such
technique, called chromatin immunoprecipitation, involves
the use of antibodies that recognize a single specific histone
Table 1 Preclinical models of drug addiction
Locomotor sensitization
Psychomotor sensitization is observed across many species,
including humans, and models some features of addiction. The
acute motor-activating response produced by administration of
psychostimulants is augmented with repeated exposure, which has
been shown in rodents to be associated with augmented drug
reward and increased vulnerability to relapse [46]. Behavioral
sensitization can be separated into two components: induction and
expression. Induction of sensitization is the progressive increase in
locomotor activity during the repeated drug treatment. Expression
of sensitization is demonstrated following challenge with a low
dose of psychostimulant after a drug-free period. This response can
persist up to 1 year after drug treatment.
Conditioned place preference
Conditioned place preference is used to evaluate the rewarding or
aversive motivational effects of drugs [47]. The primary effects of a
drug are repeatedly paired with an environmental context that
acquires the motivational properties of the drug. Animals receive
saline injections in an alternative context. Following multiple
pairings, a choice test allows the animal unrestricted access to both
contexts in the absence of drug. An increase in time spent in the
drug-paired context relative to that before drug conditioning, or
compared with the saline-paired context, is evidence that the drug
was rewarding.
Self-administration
Self-administration is a method in preclinical drug abuse research
that best models drug consumption in humans [48]. The paradigm
is based on principles of operant and classical conditioning in
which animals control the delivery of drug infusions by performing
an operant response (eg, pressing a lever or actively sniffing a
photobeam-triggered hole). Motivation to administer drugs is
assessed by progressively increasing the number of responses
required to receive a single infusion of drug. Drug self-
administration has the most direct connection to addictive behavior
in a natural environment.
Extinction and reinstatement
Extinction training is repeated re-exposure to the drug-paired
environment after removal of the unconditioned stimulus (eg, drug)
until the response is diminished to preconditioning levels. This is an
active learning process by which contextual associations no longer
predict drug availability. Reinstatement of drug-seeking behavior in
laboratory animals is induced by conditions described to trigger
drug craving and relapse in humans, such as acute re-exposure to
the drug, drug-associated cues, or stress [48]. Reinstatement
behavior is measured by the recovery of operant responding (self-
administration) or time spent in drug-paired context (conditioned
place preference) after extinction of these responses.
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modification of interest can be isolated from the rest of the
chromatin by being pulled away (immunoprecipitated) using
these antibodies. Then one can use two different approaches
to examine which genes have increases or decreases in that
histone modification at their promoter. One approach is a
direct method in which one already has a target gene of
interest, and quantitative polymerase chain reaction can be
used to amplify the promoter from the chromatin that has
been pulled down by the specific antibody. This direct
approach reveals how specific histone modifications change
before and after drug exposure and how these changes in
histone modifications correlate with altered gene expression
[31, 32]. A newer approach involves using the chromatin
that has been pulled down by specific antibodies to hybridize
it against microarrays containing promoter regions of about
20,000 genes. This approach has provided a more global
understanding of cocaine-regulated gene targets. In general,
cocaine-activated genes are marked by increased histone
acetylation, whereas genes that are repressed following
cocaine are marked by histone methylation [33••]. In
combination with examining the presence of specific
transcription factors at the promoters of genes, it is possible
to gain an understanding of how different sets of genes are
regulated in different ways [33••].
CREB is the best-characterized transcription factor
shown to direct a histone-modifying enzyme to the gene
promoter. Phosphorylated CREB at the gene promoter
region recruits CREB-binding protein (CBP), a potent
histone acetyltransferase and transcriptional coactivator that
recruits the basal transcriptional machinery [34]. CBP
acetylates histones, allowing chromatin structure to relax and
increase expression of target genes. The regulation of gene
expression by chromatin modification induced by acute
cocaine has been shown for many immediate early genes,
suchasc-fos and FosB [31, 32]. Infusions of CREB antisense
or transgenic CBP mutant mice (that demonstrate decreased
CBP function) show decreased CBP occupancy of the FosB
promoter and reduced stimulant-induced Fos activation [32,
35]. Furthermore, the drug-induced temporal pattern of
acetylation parallels the induction of mRNA expression
[31]. Whereasasingledoseofcocaineactivatesc-fos,r e p e a t e d
treatment is necessary to induce bdnf and cdk5 genes. This
pattern of gene activation is also seen with acetylation, and
chronically upregulated genes show significant acetylation
days to weeks after the last cocaine treatment [31].
ΔFosBwasrecentlyshowntorecruitchromatin-modifying
enzymes to cocaine-regulated genes. For example, the
promoters of genes chronically upregulated following drug
treatment, such as cdk5,a r eΔFosB bound and additionally
contain histone modifications. ΔFosB facilitates the recruit-
ment of transcriptional activators such as histone acetyl-
transferases, as well as Brg1-containing SWI/SNF chromatin
remodeling proteins [31]. SWI/SNF is an adenosine
triphosphate-dependent chromatin remodeling complex that
mobilizes the histone octamers. This movement permits
binding by protein complexes necessary for initiating
transcription. Overall, these findings demonstrate that CREB
and ΔFosB can recruit histone-modifying enzymes that may
mediate the persistent molecular changes caused by drugs.
Effect of Histone Deacetylase Inhibition on Drug-induced
Plasticity and Behavior
Drugs of abuse enhance histone acetylation by increasing
histone acetyltransferase or decreasing histone deacetylase
Table 2 Effects of CREB on reward-related behaviors
Study Drug exposure Model Effect of CREB Effect on behavior
Carlezon et al. [22] Cocaine CPP HSV-CREB ↑ pCREB NAcSh ↓ CPP (aversion at low dose)
HSV-mCREB ↓ pCREB NAcSh ↑ CPP at low dose
Pliakas et al. [23] Cocaine CPP HSV-CREB ↑ pCREB NAcSh ↓ CPP (aversion at low dose)
HSV-mCREB ↓ pCREB NAcSh ↑ CPP at low dose
Olson et al. [24] Cocaine CPP HSV-CREB ↑ pCREB VTA ↑ CPP in rostral, ↓ CPP in caudal portion
HSV-mCREB ↓ pCREB VTA ↓ CPP in rostral, ↑ CPP in caudal portion
Fasano et al. [26] Cocaine CPP, sensitization Str-KCREB ↓ pCREB DStr ↑ CPP and locomotor sensitization at low dose
Walters and Blendy [25] Cocaine CPP, sensitization CREBαΔ ↓ pCREB ↑ CPP, ↑ expression of locomotor sensitization
Valverde et al. [49] Cocaine CPP CREBαΔ ↓ pCREB No change in CPP at high dose
Choi et al. [26] Cocaine self-administration CREB antisense ↓ pCREB NAc ↓ cocaine intake
Analysis of CREB’s effects on behavior has been conducted in discrete brain regions such as the nucleus accumbens shell, ventral tegmental area,
and dorsal striatum
CPP conditioned place preference, CREB cyclic adenosine monophosphate response element–binding protein, DStr dorsal striatum, HSV herpes
simplex virus, KCREB mutant form of CREB that heterodimerizes with the wild-type form; mCREB mutant form of CREB, NAc nucleus
accumbens, NAcSh NAc shell, pCREB phosphorylated (activated) form of CREB, Str striatum, VTA ventral tegmental area
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administering animals have reduced HDAC activity in the
frontal cortex and NAc, resulting in increased histone
acetylation [36]. As shown in Fig. 1, a histone hyper-
acetylated state may be achieved by using HDAC inhibitors
(eg, sodium butyrate, trichostatin A), which increase global
histone acetylation. HDAC inhibition has been shown to
potentiate cocaine-induced locomotion and reward [31, 36,
37••, 38]. HDAC inhibition also has been shown to increase
drug intake in animals maintained on cocaine self-
administration but may reduce intake when given before
acquisition [36, 39]. Conversely, overexpression of HDAC4
or HDAC5, but not HDAC9, in the NAc attenuates cocaine
CPP, further supporting the hypothesis that chromatin modi-
ficationis criticaltothe regulationofgeneexpressionrequired
for changes in drug-seeking behavior [31, 37••]. Importantly,
experiments using individual HDACs provide critical insight
into which HDACs mediate drug-induced plasticity. Table 3
summarizes the effects of HDAC inhibition in models of
drug addiction.
Sirtuins, a third class of HDACs, can deacetylate
histones and nonhistone proteins, such as transcription
factors (eg, nuclear factor-κB) [40]. Chronic cocaine
exposure increases expression of Sirt1 and Sirt2. This
increased expression correlates with increased acetylation at
the Sirt1 and Sirt2 promoters, as well as increased sirtuin
enzymatic activity [33••]. Pharmacologic manipulation of
sirtuins leads to interesting changes in cocaine-induced
behavior. A sirtuin activator enhances CPP using a low
dose of cocaine, whereas a sirtuin inhibitor attenuates CPP
and reduces cocaine self-administration behavior [33••]. A
single exposure to cocaine does not alter sirtuin activity;
however, upregulation of the sirtuins after chronic cocaine
may mediate the stable neuroadaptive changes involved in
maintaining addiction. The inhibitors of class I and II
HDACs described previously increase behavioral sensitivity
to cocaine, but the inhibitors of class III HDACs (sirtuins)
reduce sensitivity, suggesting that they may work through
mechanisms beyond acetylating histones.
Behavioral and Epigenetic Mechanisms in Extinction
of Cocaine-induced Memories
Nonspecific HDAC inhibitors were recently shown to
enhance synaptic plasticity and long-term memory [10••].
For example, we recently demonstrated that the HDAC
inhibitor sodium butyrate can transform a learning event
that does not lead to long-term memory into a learning event
that does result in significant long-term memory [41••].
Furthermore, sodium butyrate also generated a form of
long-term memory that persisted beyond the point at which
normal memory failed [41••]. These demonstrations of
modulating memory via HDAC inhibition have considerable
therapeutic potential for many cognitive disorders.
For example, an exciting application for the modulation
of long-term memory via HDAC inhibition in substance
disorders is the pharmacologic enhancement of extinction
learning. After establishing a preference using the CPP
model, animals can extinguish drug-seeking behaviors after
repeated re-exposure to the drug-paired environment in the
absence of the drug. Over time, animals no longer
demonstrate drug-seeking behavior in response to the
environment, although a prime with drug administration
reinstates this action. A recent study from our laboratory
showed that HDAC inhibition after establishing a CPP
significantly facilitated extinction of drug-seeking behavior
Table 3 Effects of histone acetylation on reward-related behaviors
Study Drug exposure Model Effect of histone
acetylation
Effect on behavior
Levine et al. [32] Cocaine sensitization CBP haploinsufficient mice ↓ (↓HAT) ↓ cocaine sensitization
Kumar et al. [31] Cocaine CPP HSV-HDAC4 ↓ (↑HDAC4 NAc) ↓ CPP
TSA ↑ (↓HDAC) ↑ CPP
Renthal et al. [37••] Cocaine CPP SAHA (continuous intra-NAc) ↑ (↓ HDAC NAc) ↑ CPP
HSV-HDAC5 ↓ (↑HDAC5 NAc) ↓ CPP
HSV-HDAC9 ↓ (↑HDAC9 NAc) No change CPP
Romieu et al. [36] Cocaine self-administration TSA ↑ (↓HDAC) ↓ cocaine intake, early acquisition
Cocaine sensitization TSA 4 d prior to cocaine ↑ (↓HDAC) ↓ cocaine locomotor sensitization
Sun et al. [39] Cocaine self-administration Sodium butyrate ↑ (↓HDAC) ↑ cocaine intake, maintenance
Sanchis-Segura et al. [38] Cocaine sensitization Sodium butyrate ↑ (↓HDAC) ↑ cocaine-induced locomotion
Malvaez et al. [42••] Extinction of cocaine CPP Sodium butyrate ↑ (↓HDAC) ↑ extinction of CPP
CBP CREB-binding protein, CPP conditioned place preference, CREB cyclic adenosine monophosphate response element–binding protein, HAT
histone acetyltransferase, HDAC histone deacetylase, HSV herpes simplex virus, NAc nucleus accumbens, SAHA suberoylanilide hydroxamic acid,
TSA trichostatin A
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guished cocaine-induced CPP more quickly and to a greater
extent than did vehicle-treated animals. Even more remark-
able, the extinction of cocaine seeking via HDAC inhibition
modulates extinction learning such that reinstatement
behavior is significantly attenuated [42••], suggesting that
the HDAC inhibition-dependent extinction may be persis-
tent. These findings suggest that in a normal situation,
behavioral extinction of drug-seeking behavior, as mea-
sured by CPP, is subject to relapse-like behavior (reinstate-
ment). However, behavioral extinction in combination with
HDAC inhibition-dependent facilitation of extinction may
generate a form of extinction that is much more persistent
and thus refractive to relapse-like behavior.
Although further research is needed, this behavioral and
epigenetic approach to extinction of drug-seeking behavior
may be valuable in treating drug dependence. One caveat is
that HDAC inhibition enhances initial learning and memory
as well and, as discussed previously, has been shown to
potentiate cocaine-induced locomotion and reward [31,
37••, 38]. Thus, HDAC inhibition would have to be used
only during extinction consolidation processes.
Clinical Implications
Examining epigenetic mechanisms in human tissue poses a
much greater challenge compared with animal models.
Substance abusers vary in drug intake and exposure period
and often use multiple drugs and have comorbid psychiatric
conditions. Despite these challenges, some studies have
identified genes altered among cocaine users, many of
which overlap with gene expression profiles in animal
models [43•]. Recently, alterations in cortical gene expres-
sion showed corresponding changes in histone and DNA
methylation in these genes in postmortem brains of patients
with schizophrenia [44••]. Tsankova et al. [45••] provided
an excellent review on epigenetic regulation in psychiatric
disorders, including depression and other disorders. With
the development of powerful new techniques such as
genome-wide microarrays of chromatin modifications,
researchers can identify new gene targets underlying the
pathophysiology of addiction and compare those of animal
models to human postmortem brain data.
Conclusions
We have presented some of the growing body of evidence
for epigenetic mechanisms involved in mediating the
development and maintenance of substance abuse. Repeated
use of abused drugs causes persistent alterations in gene
expression responsible for the long-term behavioral and
structural changes. Specific transcription factors and
chromatin-modifying enzymes regulate drug-induced gene
expression during acquisition and maintenance of drug
seeking. These changes may underlie the transition from
recreational use to compulsive drug-taking behavior, and
pharmacologic tools (eg, HDAC inhibitors) in conjunction
with behavioral therapy may aid in reversing this process.
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